This inventor holds 6 USPTO granted patents, plus 1 CIPO patent. Top assignee: Northwestern University. Active years: 2001-2021.
Company Filing History:
Years Active: 2001-2021
Title: Han-Xiang Deng: Innovator in ALS Research
Introduction
Han-Xiang Deng is a prominent inventor based in Chicago, IL (US), known for his significant contributions to the field of amyotrophic lateral sclerosis (ALS) and related disorders. With a total of 6 patents, his work focuses on the molecular targets that can aid in the diagnosis and treatment of ALS.
Latest Patents
Deng's latest patents include groundbreaking inventions such as "Molecular targets for ALS and related disorders." This invention provides compositions and methods for diagnosis, risk assessment, research, and therapy related to ALS. It specifically addresses mutations in the UBQLN2 gene that lead to dominantly inherited chromosome X-linked ALS and ALS/dementia. Another notable patent is "Allelic disorders caused by mutations in TRPV4," which offers methods, kits, and compositions for detecting mutations in the TRPV4 gene. This invention is crucial for identifying diseases such as scapuloperoneal spinal muscular atrophy (SPSMA) and hereditary motor and sensory neuropathy type IIC (HMSN IIC) or Charcot-Marie-Tooth disease type 2C (CMT2C).
Career Highlights
Deng is affiliated with Northwestern University, where he conducts his research and develops innovative solutions for ALS. His work has garnered attention in the scientific community, contributing to advancements in understanding and treating this debilitating disease.
Collaborations
Deng collaborates with esteemed colleagues such as Teepu Siddique and Jianhua Yan, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Han-Xiang Deng's contributions to ALS research through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for advancements in diagnosis and treatment of ALS and related disorders.